SKYX director Efrat Greenstein Brayer dies; Nasdaq flags board/audit committee noncompliance with cure to 2027

SKYX Platforms Corp.

Independent director Efrat L. Greenstein Brayer, chair of the nominating and corporate governance committee and member of the audit and compensation committees, died September 26, 2026.
SKYX notified Nasdaq on September 28, 2026 that it no longer meets Listing Rule 5605(b)(1) (majority independent board) and Rule 5605(c)(2)(A) (three-member audit committee).
Nasdaq's September 30, 2026 letter grants a cure period expiring at the earlier of the next annual meeting or September 26, 2027; March 25, 2027 if the annual meeting is held before then.
Company says it intends to regain compliance before the cure period lapses; no immediate effect on its Nasdaq listing, and it warns there is no assurance it will succeed.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.